Response to brentuximab vedotin in advanced stage MF/Sézary syndrome with low CD-30 expression: 'real-life' data of the German Cutaneous Lymphoma Network

Autor:	Sarja Stendel, Janika Gosmann, Claus-Detlev Klemke, Ann-Kathrin Frenzel, Ulrike Wehkamp, Alexander Kreuter, Philipp Schrüfer, Christoph Blazejak, René Stranzenbach, Christina Mitteldorf, Nina Booken, Marion Wobser, Chalid Assaf, Maria Weyermann, Edgar Dippel, Jan P. Nicolay, Rudolf Stadler
Rok vydání:	2021
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Advanced stage medicine.disease Real life data language.human_language Cutaneous lymphoma German Internal medicine medicine language business Brentuximab vedotin medicine.drug
Zdroj:	European Journal of Cancer. 156:S16-S17
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d1676386876dda22eab618c1708d2056 https://doi.org/10.1016/s0959-8049(21)00656-0 Zobrazit plný text záznamu Full Text from ScienceDirect